TCGA-BRCA
Benchmarks
| Task Name | Dataset Name | SOTA Result | Trend | |
|---|---|---|---|---|
| Cancer Classification | TCGA-BRCA | Accuracy98.3 | 94 | |
| Survival Prediction | TCGA-BRCA (test) | Concordance Index (CI)0.81 | 67 | |
| Survival Prediction | TCGA-BRCA (5-fold cross-validation) | C-Index0.744 | 54 | |
| Weakly Supervised Classification | TCGA-BRCA Few-shot | Accuracy88.23 | 36 | |
| PR status classification | TCGA-BRCA | AUC0.9174 | 27 | |
| ER Status Prediction | TCGA-BRCA internal cohort | AUC99.4 | 26 | |
| Survival Prediction | TCGA-BRCA (N=899) | C-index0.692 | 21 | |
| Slide-Level Classification | TCGA-BRCA (10-fold cross-validation) | F1 Score86.6 | 17 | |
| Cancer Subtyping | TCGA-BRCA (test) | AUC95.2 | 17 | |
| HER2 Status Prediction | TCGA-BRCA internal cohort | AUC (%)95.76 | 14 | |
| PR Status Prediction | TCGA-BRCA internal cohort | AUC91.79 | 14 | |
| Tumor Segmentation | TCGA-BRCA (target) | DSC0.7008 | 13 | |
| Risk Prediction | TCGA-BRCA patient-level 5-fold CV | C-index0.735 | 12 | |
| Cancer Subtype Classification | TCGA-BRCA patient-level 5-fold CV | Macro AUC99.5 | 12 | |
| HER2 Status Prediction | TCGA-BRCA patient-level 5-fold CV | AUC0.865 | 12 | |
| PR Status Prediction | TCGA-BRCA patient-level 5-fold CV | AUC97.8 | 12 | |
| WSI Classification | TCGA-BRCA (test) | F1 Score93.08 | 9 | |
| Uncertainty Estimation | TCGA-BRCA | MSE0.4498 | 9 | |
| ODX status classification | TCGA-BRCA | AUC82.3 | 9 | |
| Breast cancer tumor subtyping | TCGA-BRCA WSI (test) | AUPRC0.6692 | 9 | |
| Slide-Level Subtyping | TCGA-BRCA 100% (train) | Macro AUC87.4 | 9 | |
| Slide-Level Subtyping | TCGA-BRCA (25% train) | Macro AUC0.821 | 9 | |
| Gene-protein pair detection | TCGA-BRCA | Total Detected Pairs126,600 | 8 | |
| HRD prediction | TCGA-BRCA | AUROC (>42)0.8367 | 8 | |
| Whole Slide Image Classification | TCGA-BRCA (five-fold cross-validation) | ACC90.43 | 8 |
Showing 25 of 38 rows